ArticleMetallomics : integrated biometal science2026
Copper restriction unmasks axonal degeneration in a mouse model of X-linked hereditary motor neuropathy.
Article in Metallomics : integrated biometal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Mutations in the copper (Cu) transporter ATP7A cause a spectrum of X-linked diseases, including Menkes Disease, Occipital horn syndrome, and distal hereditary motor neuropathy (dHMNX). We previously generated a conditional knock-in mouse model of dHMNX expressing Atp7aT985I, the murine orthologue of the human T994I variant identified in dHMNX patients. Although Atp7aT985I mice did not develop overt motor degeneration, affected males showed a trend toward reduced Cu levels in the peripheral nervous system (PNS). The high-affinity copper transporter Ctr1, encoded by Slc31a1, regulates Cu uptake, and ubiquitous heterozygosity for Slc31a1 (Ctr1+/-) has been reported to limit Cu availability in the nervous system without impairing motor performance. In this study, we genetically restricted Cu availability in Atp7aT985I mice by crossing them with Ctr1+/- animals. Atp7aT985I/Ctr1+/- males exhibited significantly reduced Cu levels in both the central nervous system and PNS compared to wild-type littermates. At 6 months of age, behavioural testing and histopathological assessment revealed mild motor deficits and axonal loss, preferentially affecting small-caliber fibres exclusively in the Cu-restricted Atp7aT985Imales. Tandem mass tag-based proteomics of sciatic nerve identified significant changes linked to energy metabolism, cytoskeletal integrity, and cellular stress responses. Together, these data show that limiting Cu availability unmasks a dHMNX-like phenotype in Atp7aT985I/Ctr1+/- mice, demonstrate the critical role of Cu availability in maintaining peripheral axons and suggest that reduced Cu in motor neurons contributes to axonal degeneration in dHMNX.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.